Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 3/20 | 0.59 |
| ▸ | NOS1 | P29475 | 3/20 | 0.59 |
| ▸ | NOS2 | P35228 | 3/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.58 |
| ▸ | PKM | P14618 | 2/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.51 |
| ▸ | MPO | P05164 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43864 | 1.00 | NOS3 (0.59) | NOS3NOS1NOS2SLC7A5PKM | |
| SCHEMBL43865 | 1.00 | NOS3 (0.59) | NOS3NOS1NOS2SLC7A5PKM | |
| SCHEMBL29379111 | 1.00 | NOS3 (0.59) | NOS3NOS1NOS2SLC7A5PKM | |
| Hydrochloric Acid SCHEMBL28690926 | 0.98 | NOS3 (0.58) | NOS3NOS1NOS2SLC7A5PKM | |
| Hydrochloric Acid SCHEMBL28690928 | 0.98 | NOS3 (0.58) | NOS3NOS1NOS2SLC7A5PKM | |
| Dl-Phenylalanine SCHEMBL23214377 | 0.93 | SLC7A5 (0.71) | NOS3NOS1NOS2SLC7A5PKM | |
| SCHEMBL27464327 | 0.87 | NOS3 (0.48) | NOS3NOS1NOS2SLC7A5PKM | |
| SCHEMBL13971424 | 0.86 | SLC7A5 (0.69) | NOS3NOS1NOS2SLC7A5PKM | |
| SCHEMBL9164980 | 0.86 | SLC7A5 (0.69) | NOS3NOS1NOS2SLC7A5PKM | |
| SCHEMBL5326602 | 0.86 | NOS3 (0.53) | NOS3NOS1NOS2SLC7A5PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192379-A | Marine cyclic peptide and synthesis method and application thereof | 内蒙古大学 | 2025-06-24 | — | — | CN | claimed |
| EP-3464324-B1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | FERRING BV (NL) | 2021-04-07 | — | — | EP | claimed |
| US-20200102348-A1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | FERRING B.V. (NL) | 2020-04-02 | — | — | US | claimed |
| US-10344054-B2 | Angiotensin-1-receptor antagonists | FERRING B.V. (NL) | 2019-07-09 | — | — | US | claimed |
| EP-3464324-A1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | Ferring B.V. (NL) | 2019-04-10 | — | — | EP | claimed |
| CN-109311942-A | Angiotensin-1 receptor antagonists | 辉凌公司 | 2019-02-05 | — | — | CN | claimed |
| US-20170349629-A1 | Angiotensin-1-Receptor Antagonists | FERRING B.V. (NL) | 2017-12-07 | — | — | US | claimed |
| WO-2017207760-A1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | FERRING B.V. (NL) | 2017-12-07 | — | — | WO | claimed |
| CN-106219911-A | The processing system of a kind of rolling effluent and processing method thereof | 山东钢铁股份有限公司 | 2016-12-14 | — | — | CN | claimed |
| US-20160022636-A1 | PHYSIOLOGICAL LIGANDS FOR GPR139 | JANSSEN PHARMACEUTICA NV (BE) | 2016-01-28 | — | — | US | claimed |
| CN-101107264-A | C5a receptor antagonists | JERINI AG (DE) | 2008-01-16 | — | — | CN | claimed |
| JP-2007534619-A | — | — | 2007-11-29 | — | — | JP | claimed |
| US-20070254831-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn | BIOGEN HEMOPHILIA INC. | 2007-11-01 | — | — | US | claimed |
| EP-1838725-A1 | C5A RECEPTOR ANTAGONISTS | Jerini AG (DE) | 2007-10-03 | — | — | EP | claimed |
| WO-2007098420-A2 | PEPTIDES THAT BLOCK THE BINDING OF IGG TO FCRN | SYNTONIX PHARMACEUTICALS, INC. (US) | 2007-08-30 | — | — | WO | claimed |
| US-20060183883-A1 | C5a Receptor antagonists | JERINI AG (DE) | 2006-08-17 | — | — | US | claimed |
| WO-2006074964-A1 | C5A RECEPTOR ANTAGONISTS | JERINI AG (DE) | 2006-07-20 | — | — | WO | claimed |
| EP-1646643-A2 | C5A RECEPTOR ANTAGONISTS | Jerini AG (DE) | 2006-04-19 | — | — | EP | claimed |
| WO-2005010030-A2 | C5A RECEPTOR ANTAGONISTS | JERINI AG (DE) | 2005-02-03 | — | — | WO | claimed |
| EP-1498422-A1 | C5a Receptor Antagonists | Jerini AG (DE) | 2005-01-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349629-A1 | Angiotensin-1-Receptor Antagonists | AGTR1, AGTR2, REN | NOS3 1053/4885NOS1 956/4885NOS2 1445/4885 |
| US-20200102348-A1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | AGTR1, AGTR2, REN | NOS3 1053/4885NOS1 956/4885NOS2 1445/4885 |
| US-10344054-B2 | Angiotensin-1-receptor antagonists | AGTR1, AGTR2, AGT | NOS3 970/4885NOS1 760/4885NOS2 1182/4885 |
| US-20060183883-A1 | C5a Receptor antagonists | C5AR1, C3AR1, C5AR2 | NOS3 369/4885NOS1 610/4885NOS2 811/4885 |
| US-20070254831-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn | FCGRT, FCGR3B, FCGR1A | NOS3 1962/4885NOS1 2538/4885NOS2 2254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.